A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00420784

Locations


United States, Alabama
	Birmingham Gastroenterology Associates
	Birmingham, Alabama, United States

United States, California
	Kaiser Permanente Hepatology Research
	San Diego, California, United States
	USC
	Los Angeles, California, United States
	University of California, San Diego
	San Diego, California, United States
	Cedars-Sinai Medical Center
	Los Angeles, California, United States, 90048
	University of California San Francisco
	San Francisco, California, United States

United States, Colorado
	University of Colorado Health Sciences Center
	Denver, Colorado, United States

	Englewood, Colorado, United States

United States, Florida
	University of Florida
	Gainesville, Florida, United States

	Miami, Florida, United States
	University Hepatitis Center at Bach & Godofsky
	Sarasota, Florida, United States

	Bardenton, Florida, United States
	Borland-Groover Clinic
	Jacksonville, Florida, United States
	Mayo Clinic Jacksonville
	Jacksonville, Florida, United States

United States, Georgia

	Atlanta, Georgia, United States

United States, Illinois

	Chicago, Illinois, United States

United States, Indiana

	Indianapolis, Indiana, United States

United States, Louisiana
	Gulf Coast Research, LLC
	Baton Rouge, Louisiana, United States

United States, Maine
	Virology Treatment Center, Maine Medical Center
	Portland, Maine, United States

United States, Maryland
	Johns Hopkins University
	Baltimore, Maryland, United States

United States, Massachusetts
	Beth Isreal Deaconess Medical Center
	Boston, Massachusetts, United States

United States, Michigan
	Henry Ford Hospital
	Detroit, Michigan, United States

United States, Missouri
	Saint Louis University
	St Louis, Missouri, United States

United States, Nebraska

	Omaha, Nebraska, United States

United States, New Mexico

	Albuquerque, New Mexico, United States

United States, New York

	New York, New York, United States
	North Shore University Hospital
	Manhasset, New York, United States

United States, North Carolina

	Durham, North Carolina, United States

United States, Ohio
	University Internal Medicine Associates, Inc.
	Cincinnati, Ohio, United States
	Cleveland Clinic
	Cleveland, Ohio, United States

United States, Pennsylvania

	Hershey, Pennsylvania, United States

	Pittsburgh, Pennsylvania, United States

United States, South Carolina
	Columbia Gastroenterology Associates, PA
	Columbia, South Carolina, United States

United States, Tennessee
	Memphis Gastroenterology Group
	Germantown, Tennessee, United States

United States, Texas
	Alamo Medical Research
	San Antonio, Texas, United States
	Advanced Liver Therapies
	Houston, Texas, United States
	Liver Institute at Methodist Dallas
	Dallas, Texas, United States

United States, Virginia

	Annandale, Virginia, United States

	Richmond, Virginia, United States
	Metropolitan Research
	Fairfax, Virginia, United States

United States, Washington

	Seattle, Washington, United States

Canada, Alberta
	University of Calgary Medical Clinic - Health Science Centre
	Calgary, Alberta, Canada, T2N 4N1

	Edmonton, Alberta, Canada

Canada, British Columbia
	BC Hepatitis Program
	Vancouver, British Columbia, Canada

Canada, Manitoba

	Winnipeg, Manitoba, Canada

Canada, Ontario
	Toronto Western Hospital
	Toronto, Ontario, Canada

	Toronto, Ontario, Canada

Germany
	University Clinic Frankfurt, Department of Internal Medicine
	Frankfurt, Germany
	Universitatsmedizin Berlin
	Berlin, Germany

Netherlands
	Leiden University Medical Center
	Leiden, Netherlands
	Academic Medical Center
	Amsterdam, Netherlands
	Erasmus MC University Medical Center
	Rotterdam, Netherlands

Puerto Rico

	Santurce, Puerto Rico

Sponsors and Collaborators

Vertex Pharmaceuticals Incorporated

Investigators


Study Director:	Medical Monitor	Vertex Pharmaceuticals Incorporated